Interleukin- 2 production during murine infection by Leishmania mexicana amazonensis

Interleukin- 2 production during murine infection by Leishmania mexicana amazonensis

Highly susceptible BALB/c mice, resistant C57B1/6 and their F1 progeny (BDF1) were infected subcutaneously in the foot pad with Leishmania mexicana amazonenesis. At various times after infection, spleen or draining popliteal lymph node cells were assayed for their capacity to generate Interleukin-2...

Full description

Bibliographic Details
Main Authors:	Manoel Barral-Netto, Silene B. Roters, Aldina Barral
Format:	Article
Language:	English
Published:	Instituto Oswaldo Cruz, Ministério da Saúde 1986-03-01
Series:	Memórias do Instituto Oswaldo Cruz.
Subjects:	cutaneous leishmaniasis Interleukin-2 Leishmania (immunology) murine leishmaniasis lymphokines
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02761986000100005

Similar Items

Leishmania braziliensis: partial control of experimental infection by interleukin-12 p40 deficient mice
by: Sebastião Martins de Souza-Neto, et al.
Published: (2004-05-01)

Experimental infection of Lutzomyia longipalpis fed on a patient with cutaneous leishmaniasis due to Leishmania mexicana amazonensis
by: Leonidas M. Deane, et al.
Published: (1986-03-01)

The role of complement in the early phase of Leishmania (Leishmania) amazonensis infection in BALB/c mice
by: M.D. Laurenti, et al.
Published: (2004-03-01)

Atividade leishmanicida de extrato hidroalcoólico de própolis brasileira em Leishmania amazonensis
by: Suelen Santos da Silva, et al.
Published: (2015-12-01)

The histopathology of cutaneous leishmaniasis due to Leishmania (Leishmania) mexicana in the Yucatan peninsula, Mexico Histopatologia de la leishmaniasis cutánea causada por Leishmania (Leishmania) mexicana en la península de Yucatán, México
by: Fernando J. Andrade-Narvaez, et al.
Published: (2005-08-01)

Leishmania Parasites Drive PD-L1 Expression in Mice and Human Neutrophils With Suppressor Capacity
by: Alessandra M. da Fonseca-Martins, et al.
Published: (2021-06-01)

Leishmania donovani Nucleoside Hydrolase terminal domains in cross-protective immunotherapy against Leishmania amazonensis murine infection
by: Dirlei eNico, et al.
Published: (2014-06-01)

IL-32γ promotes the healing of murine cutaneous lesions caused by Leishmania braziliensis infection in contrast to Leishmania amazonensis
by: Rodrigo Saar Gomes, et al.
Published: (2017-07-01)

Analysis of the Antigenic and Prophylactic Properties of the Leishmania Translation Initiation Factors eIF2 and eIF2B in Natural and Experimental Leishmaniasis
by: Esther Garde, et al.
Published: (2018-04-01)

Cell migration induced by Leishmania (Leishmania) amazonensis, Leishmania (Leishmania) major and Leishmania (Viannia) braziliensis into the peritoneal cavity of BALB/c mice
by: DT Wakimoto, et al.
Published: (2010-01-01)

Leishmania martiniquensis is a New Causative Agent for Cutaneous and Visceral Leishmaniasis in Humans
by: S. B. Chuelov, et al.
Published: (2018-12-01)

Comparison of small mammal prevalence of Leishmania (Leishmania) mexicana in five foci of cutaneous leishmaniasis in the State of Campeche, Mexico Comparación de las prevalencias de Leishmania (Leishmania) mexicana en mamíferos pequeños en cinco focos de leishmaniosis cutánea en el estado de Campeche, México
by: N.R. Van Wynsberghe, et al.
Published: (2009-04-01)

Mucosal Leishmaniasis in Travelers with Leishmania braziliensis Complex Returning to Israel
by: Michal Solomon, et al.
Published: (2019-04-01)

Disseminated cutaneous leishmaniasis due to Leishmania (Leishmania) amazonensis in human immunodeficiency virus (HIV)-infected patients: A report of two cases
by: Camila F Araujo, et al.
Published: (2021-01-01)

Distinct ultrastructural aspects in different biopsies of a single patient with diffuse cutaneous leishmaniasis
by: Achilea Lisboa Bittencourt, et al.
Published: (1990-03-01)

Efficacy of topical risedronate and risedronate - Eudragit E complex in a model of cutaneous leishmaniasis induced by Leishmania (Leishmania) amazonensis
by: Ma. Florencia Peralta, et al.
Published: (2021-05-01)

Cutaneous Leishmaniasis Caused by an Unknown Leishmania Strain, Arizona, USA
by: Marcos de Almeida, et al.
Published: (2021-06-01)

Further observations on clinical, histopathological, and immunological features of borderline disseminated cutaneous leishmaniasis caused by Leishmania (Leishmania) amazonensis
by: Fernando T Silveira, et al.
Published: (2005-08-01)

Leishmania life cycle images in the cutaneous cytologic smear of an immunocompetent patient
by: Zappacosta Roberta, et al.
Published: (2010-01-01)

Interleukin-4 Receptor Alpha: From Innate to Adaptive Immunity in Murine Models of Cutaneous Leishmaniasis
by: Ramona Hurdayal, et al.
Published: (2017-11-01)

FIRST REPORT OF CUTANEOUS LEISHMANIASIS CAUSED BY Leishmania (Leishmania) infantum chagasi IN AN URBAN AREA OF RIO DE JANEIRO, BRAZIL
by: Marcelo Rosandiski LYRA, et al.
Published: (2015-10-01)

Reacción de antígenos de Leishmania (Leishmania) mexicana con sueros de pacientes con leishmaniosis cutánea de Sinaloa, México Reaction of Leishmania (Leishmania) mexicana antigens by sera of patients with cutaneous leishmaniasis from Sinaloa, Mexico
by: Patricia Guadalupe Salazar-Mejía, et al.
Published: (2010-04-01)

Natural canine infection by Leishmania infantum and Leishmania amazonensis and their implications for disease control
by: Letícia da Cruz Sanches, et al.

Cross-protective immunity to Leishmania amazonensis is mediated by CD4+ and CD8+-epitopes of Leishmania donovani Nucleoside Hydrolase terminal domains
by: Dirlei eNico, et al.
Published: (2014-05-01)

Impact of leishmaniasis on public health
by: L. B Camargo, et al.
Published: (2006-01-01)

Caracterização da região genômica META 1 de Leishmania (Leishmania) amazonensis e comparação com a região ortóloga de L. (L.) major.
by: Fernando Alves de Lima Franco
Published: (2008)

Caracterização da região genômica META 1 de Leishmania (Leishmania) amazonensis e comparação com a região ortóloga de L. (L.) major.
by: Franco, Fernando Alves de Lima
Published: (2008)

The Role of Phosphoglycans in the Susceptibility of Leishmania mexicana to the Temporin Family of Anti-Microbial Peptides
by: Gabriela A. Eggimann, et al.
Published: (2015-02-01)

Interleukin-10 and Transforming Growth Factor-β in Early and Late Lesions of Patients with Leishmania major induced Cutaneous Leishmaniasis
by: A Khamesipour, et al.
Published: (2012-06-01)

Interleukin-10 and Transforming Growth Factor-β in Early and Late Lesions of Patients with Leishmania major induced Cutaneous Leishmaniasis
by: SH Hejazi, et al.
Published: (2012-06-01)

Comparison of the specificity of PCR and the histopathological detection of leishmania for the diagnosis of American cutaneous leishmaniasis
by: A.C.R. Medeiros, et al.
Published: (2002-04-01)

Interleukin-10 and Transforming Growth Factor-β in Early and Late Lesions of Patients with Leishmania major Induced Cutaneous Leishmaniasis
by: A Khamesipour, et al.
Published: (2012-09-01)

Interleukin-10 and Transforming Growth Factor-β in Early and Late Lesions of Patients with Leishmania major Induced Cutaneous Leishmaniasis
by: SH Hejazi, et al.
Published: (2012-09-01)

Active cutaneous leishmaniasis in Brazil, induced by Leishmania donovani chagasi
by: M. P. Oliveira Neto, et al.
Published: (1986-09-01)

Leishmania (Viannia) panamensis - induced cutaneous leishmaniasis in susceptible and resistant mouse strains Leishmaniose cutânea induzida pela Leishmania (Viannia) panamensis em linhagens de camundongos suscetíveis e resistentes
by: H. Goto, et al.
Published: (1995-12-01)

Effects of Brazilian propolis on Leishmania amazonensis
by: Diana Copi Ayres, et al.
Published: (2007-03-01)

Outbreak of cutaneous leishmaniasis in the Rio Doce Valley, Minas Gerais, Brazil
by: Marco Victor Hermeto, et al.
Published: (1994-12-01)

O uso da associação azitromicina e N-metil glucamina no tratamento da leishmaniose cutânea causada por Leishmania (Leishmania) amazonensis em camundongos C57BL6 The use of azythromycin and N-methyl glucamine for the treatment of cutaneous Leishmaniasis caused by Leishmania (Leishmania) amazonensis in C57BL6 mice
by: Raimunda Nonata Ribeiro Sampaio, et al.
Published: (2009-04-01)

Leishmania infantum AS A CAUSATIVE AGENT OF CUTANEOUS LEISHMANIASIS IN THE STATE OF MATO GROSSO DO SUL, BRAZIL
by: Ludiele Souza CASTRO, et al.
Published: (2016-01-01)

Molecular Characterization of Clinical Leishmania Major Isolates Harboring ITS1 Homology Similar to the One in Crithidia spp.
by: Mina Aghai-Maybodi, et al.
Published: (2018-12-01)

Cannot write session to /tmp/vufind_sessions/sess_ap19fn8gqc18cnvg5pbmrg73o2